Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Local versus systemic dexamethasone during thyroidectomy for postoperative complications
IRCT20220916055970N1Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Jan 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, triple-blind trial of dexamethasone in thyroid disease (3 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Calcium level the day after surgery and Postoperative pain score. Started Jan 2023; status: completed.
02
Drugs
dexamethasone
03
Conditions
thyroid disease
Beyond the preview
Go deeper on IRCT20220916055970N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220916055970N1.